Your Top 100 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
VP1-2023: Pembrolizumab (pembro) plus chemotherapy (chemo) as first-line therapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Phase III KEYNOTE-859 study
Sun Young Rha, L.S. Wyrwicz, Patricio Eduardo Yanez Weber, Yibing Bai, M.-H. Ryu, J. Lee and 14 more
- Rank
- 53 of 3,639
- Percentile
- top 1.5%
- Where
- Annals of Oncology, 2023
- Citations
- 68
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.